SHARE
Platelet Rich Plasma Market

Platelet Rich Plasma Market Forecasts to 2028 – Global Analysis By Product (L-PRP, L-PRF), Application (Dermatology, Dentistry), Growth Factor Molecule (VEGF, EGF), End User (Clinics, Physician's office) and By Geography

4.3 (83 reviews)
Published: June 2021 ID: SMRC20632
4.3 (83 reviews)
Published: June 2021 ID: SMRC20632

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Platelet Rich Plasma market is accounted for $476.10 million in 2020 and is expected to reach $1,358.12 million by 2028 growing at a CAGR 14.0% during the forecast period. The rise in the number of cosmetic surgeries, approval of new devices & the discovery of new application areas and increase in the number of orthopaedic surgeries & sports injuries are the major factors driving the market growth. However, high cost of the treatment is restraining the market growth.
 

Platelet rich plasma (PRP) is derived from blood, extractor to remove red blood cells and is also known as platelet rich gel, platelet enriched plasma, platelet enriched gel and autologous conditioned plasma. It is produced when the human blood is turned down and the platelet rich plasma gets separate that have a concentration of platelets above the normal values. It aid in blood thickening and also to boost the ligaments, healing of muscles. PRP is extremely rich in healing factors and connective tissue growth. It combines modern technology with body’s own ability to rebuild itself. PRP therapy has an extensive application in cosmetic industry.

Based on product type, the leukocyte rich platelet rich plasma (L-PRP) segment is estimated to have a lucrative growth, due to the potential risks associated with leukocyte rich PRP, this market space is witnessing a significant increase in the commercial pool and number of experimental systems and expanding potential applications across orthopedic, general surgery, and sports medicine. By geography, North America is going to have high growth during forecast period due to rising incidence of orthopedic diseases, rise in demand for cosmetic surgeries along with the approvals of various products by the U.S. FDA and growing awareness amongst the patient population in this particular region.

Some of the key players profiled in the Platelet Rich Plasma Market include AdiStem Ltd, Arthrex Inc, DePuy Synthes Companies (Johnson & Johnson), Dr. PRP USA LLCE, EmCyte Corporation, Glofinn Oy, Immer Biomet Holdings Inc, ISTO Biologics, Regen Lab, Arthrex Inc, Stryker Exactech Inc, T-Biotechnology, ThermoGenesis Holdings Inc, Vertical Spine LLC, Zimmer Biomet Company.

 

Report Coverage

Details

Published Year:

2021

Estimated Market Size in 2020:

USD 476.10 million

Estimated Period:

2020

Compound Annual Growth Rate (CAGR) from 2020 to 2028:

14.0%

Predicted 2028 Value:

USD 1,358.12 million

Forecast Years:

2021-2028

Tables, Graphs & Figures

660

Chapters Covered:

Product, Source/Origin, Application, Growth Factor Molecule, End User and Region

Core Drivers and Opportunities:

  • Rise in the number of cosmetic surgeries
  • Increase in the number of orthopedic surgeries & sports injuries
  • Extending applications of PRP treatment

Restraining Factors & Market Threats:

  • High cost of the treatment

 

Products Covered:
• Instruments
• Leukocyte Rich Platelet Rich Plasma (L-PRP)
• Leukocyte-Rich Platelet Rich Fibrin (L-PRF)
• Platelet Rich Plasma (PRP) Gel
• Pure Platelet Rich Plasma (P-PRP)
• Pure Platelet-Rich Fibrin (P-PRF)

Source /Origin Covered:
• Autologous
• Allogeneic
• Homologous

Applications Covered:
• Sports Medicine
• Cosmetic Surgery and Dermatology
• Orthopedic/Spinal Surgery
• Dermatology
• Ophthalmic Surgery
• Neurosurgery
• General Surgery
• Dentistry
• Cardiac Muscle Injury
• Nerve Injury
• Periodontal Surgery
• Aesthetics
• Other Applications

Growth Factor Molecules Covered:
• Platelet-Derived Growth Factor (PDGF)
• Vascular Endothelial Growth Factor (VEGF)
• Epidermal Growth Factor (EGF)
• Fibroblast Growth Factor-2 (FGF-2)
• Insulin-like Growth Factor (IGF)

End Users Covered:
• Hospitals & Clinics 
• Academic & Research Institutes 
• Orthopedic Clinics
• Cosmetic/Dermatology/Trichology Clinics
• Physician's office/Private Practice
• Ophthalmic Clinics


Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
        
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years (2019, 2020, 2021, 2025, and 2028)
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Key Questions Answered In The Report

The Global Platelet Rich Plasma Market is majorly driven by rise in the number of cosmetic surgeries, approval of new devices & the discovery of new application areasand increase in the number of orthopaedic surgeries & sports injuries.

The leukocyte rich platelet rich plasma (L-PRP) segment is growing at a highest CAGR owing to the potential risks associated with leukocyte rich PRP.

Asia Pacific dominated with a significant market share due to the factors such asincrease in medical tourism, technological advancements and rapid adoption of cosmetic surgeries.

North America market is growing at a highest CAGR owing to rising incidence of orthopedic diseases in the region.

Key players in Platelet Rich Plasma Market include AdiStem Ltd, ArthrexInc, DePuySynthes Companies (Johnson & Johnson), Dr. PRP USA LLCE, EmCyte Corporation, GlofinnOy, Immer Biomet Holdings Inc, ISTO Biologics, Regen Lab, ArthrexInc, Stryker ExactechInc, T-Biotechnology, ThermoGenesis Holdings Inc, Vertical Spine LLC and Zimmer Biomet Company.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials